Condition

Retinal Vein Occlusion

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 26 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials26

Recruiting5

Common interventions25

Lead sponsors shown15

Clinical trials

26 shown

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumNCT04008121 · 2025-11-06

Effect of Video Viewing on Intravitreal Injection ExperienceNCT07002372 · 2025-05-05

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseNCT04505618 · 2019-10-01

Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic RetinopathiesNCT03680794 · 2018-06-27

National Eye Institute Biorepository for Retinal DiseasesNCT01496625 · 2012-06-18

Changes in Intraocular Pressure After Intravitreal InjectionNCT07826286 · 2026-10-01

NOT_YET_RECRUITING

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic RetinopathyNCT07501052 · 2026-05-13

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsNCT07456826 · 2026-03-31

ENROLLING_BY_INVITATION

AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and GlaucomaNCT07318428 · 2026-02-20

Wide Field OCTA in Ocular DiseasesNCT07298174 · 2026-01-01

NOT_YET_RECRUITING

Intraoperative Application of Fluorescein Sodium Angiography in Vascular RetinopathyNCT06343961 · 2024-04-18

OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVONCT06332690 · 2023-10-17

Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus ImagesNCT06213896 · 2023-03-01

High Resolution Optical Coherence TomographyNCT05130385 · 2021-11-30

Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographNCT04723160 · 2020-08-10

Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and OxymapNCT02521116 · 2016-02-01

Study of the Retinal Vascularization by Laser Doppler Velocimetry Coupled With an Adaptive Optics Camera ( AO-LDV)NCT03525132 · 2015-09-18

SD-OCT AngiographyNCT02510885 · 2015-07-01

Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionNCT02486484 · 2015-03-01

Resistance to Antibiotics in Patients Receiving Eye InjectionsNCT02126423 · 2014-05-01

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular ImagingNCT01717937 · 2013-02-01

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLONCT01692938 · 2012-10-01

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the RetinaNCT02088151 · 2010-06-01

Transcorneal Electrical Stimulation Therapy for Retinal DiseaseNCT00804102 · 2008-01-01

Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersNCT00101764 · 2005-01-05

Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersNCT00071227 · 2003-10-15

Common interventions

AngioVue SD-OCTDEVICE1 Axial Length Measurement DeviceDEVICE1 Chloroprocaine Ophthalmic Gel 3% (IHEEZO)DRUG1 Color Fundus PhotographyPROCEDURE1 Conjunctival and nasopharyngeal swabsOTHER1 dexamethasone implantDEVICE1 DTL-electrode attached without energyDEVICE1 Dynamic Vessel AnalyzerOTHER1 EyeCheckup v2.0DEVICE1 Fluorescein sodium and commercially available optical angiography imaging systemCOMBINATION_PRODUCT1 Fluorescein sodium and Zeiss FF450 fundus cameraCOMBINATION_PRODUCT1 Fundus ImagingDEVICE1 High-resolution optical coherence tomography (High-Res-OCT)DEVICE1 Intraoperative Fluorescein AngiographyPROCEDURE1 Laser Doppler Velocimetry + Optic Adaptative CameraPROCEDURE1 Lidocaine Hydrochloride Injection 2%DRUG1 MB-102 and commercially available optical angiography imaging systemCOMBINATION_PRODUCT1 MB-102 and Zeiss FF450 fundus cameraCOMBINATION_PRODUCT1 Mydriatic AgentDRUG1 Oxymap T1OTHER1 Phase variance optical coherence tomography (PV-OCT)PROCEDURE1 Procedure video viewingBEHAVIORAL1 Proparacaine Hydrochloride Ophthalmic Solution 0.5%DRUG1 sampling of ophthalmic liquidOTHER1 SCD411 0.05mL (2mg)DRUG1

Leading sponsors

National Eye Institute (NEI)3 Insel Gruppe AG, University Hospital Bern2 Assiut University1 CHU de Reims1 Duke University1 Harrow Inc1 Inje University1 IRCCS Multimedica1 IRCCS San Raffaele1 Jie Zhong1 Johns Hopkins University1 MediBeacon1 Medical University of Vienna1 Okuvision GmbH1 Optos, PLC1

Trial status mix

COMPLETED10

RECRUITING5

UNKNOWN5

TERMINATED3

NOT_YET_RECRUITING2

ENROLLING_BY_INVITATION1

Phase mix

NA10

PHASE12

PHASE22

EARLY_PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.